Cancer
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
January 7, 2019
January 4, 2019
January 3, 2019
January 2, 2019
December 31, 2018
December 28, 2018
December 27, 2018
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community